KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) EBIT (2016 - 2025)

Historic EBIT for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $1.9 billion.

  • Thermo Fisher Scientific's EBIT rose 560.39% to $1.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 billion, marking a year-over-year increase of 462.72%. This contributed to the annual value of $7.3 billion for FY2024, which is 696.89% up from last year.
  • As of Q3 2025, Thermo Fisher Scientific's EBIT stood at $1.9 billion, which was up 560.39% from $1.8 billion recorded in Q2 2025.
  • Thermo Fisher Scientific's 5-year EBIT high stood at $3.0 billion for Q2 2021, and its period low was $1.6 billion during Q2 2023.
  • In the last 5 years, Thermo Fisher Scientific's EBIT had a median value of $1.9 billion in 2022 and averaged $2.0 billion.
  • As far as peak fluctuations go, Thermo Fisher Scientific's EBIT soared by 23653.42% in 2021, and later tumbled by 4459.41% in 2023.
  • Thermo Fisher Scientific's EBIT (Quarter) stood at $2.5 billion in 2021, then dropped by 26.67% to $1.9 billion in 2022, then fell by 0.38% to $1.9 billion in 2023, then grew by 8.74% to $2.0 billion in 2024, then dropped by 3.72% to $1.9 billion in 2025.
  • Its EBIT stands at $1.9 billion for Q3 2025, versus $1.8 billion for Q2 2025 and $1.7 billion for Q1 2025.